Lakefront Biotherapeutics NV(DE:GXE)
€30.02+0.48 (+1.62%)
DE:GXE
Lakefront Biotherapeutics NV Revenue
€30.02
At close:+0.48 (+1.62%)
Lakefront Biotherapeutics NV (GXE) Revenue
6 Followers
Lakefront Biotherapeutics NV Revenue
Lakefront Biotherapeutics NV had a revenue of 6.48M in the quarter ending Mar 31, 2026, with -99.28%. This bring the company's revenue in the last twelve months to 1.04B, Decreased 6.16%. In the fiscal year ending Dec 31, 2025, Lakefront Biotherapeutics NV had annual revenue of 1.11B with 303.50% growth.
- Revenue (ttm)
- 1.04B
- Revenue Growth
- 259.41%
- P/S Ratio
- 1.75
- Revenue/Employee
- EUR 2,460,726
- Employees
- 452
- Market Cap
- EUR 1.94B
Revenue Chart
Lakefront Biotherapeutics NV Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.11B | 836.60M | 303.50% |
| Dec 31, 2024 | 275.65M | 35.92M | 14.99% |
| Dec 31, 2023 | 239.72M | -265.56M | -52.56% |
| Dec 31, 2022 | 505.28M | 20.43M | 4.21% |
| Dec 31, 2021 | 484.85M | 6.79M | 1.42% |
| Dec 31, 2020 | 478.05M | -366.93M | -43.42% |
| Dec 31, 2019 | 844.99M | 556.15M | 192.55% |
| Dec 31, 2018 | 288.84M | 161.75M | 127.27% |
| Dec 31, 2017 | 127.09M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.